CCN1 and breast cancer: Of all analyzed tissue sections 82.2% expressing CYR61 did express S100A4, respectively, which lead to the conclusion, that CYR61 together with S100A4 would be valuable prognostic marker for breast cancer and breast cancer metastasis.